ACM
CORZ icon

Aurelius Capital Management’s Core Scientific CORZ Stock Holding History

Aurelius Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8.45M Buy
470,965
+32,571
+7% +$478K 15.31% 2
2025
Q2 		$7.48M Sell
438,394
-236,058
-35% -$2.36M 50.88% 1
2025
Q1 		$4.88M Sell
674,452
-602,525
-47% -$6.86M 51.63% 1
2024
Q4 		$17.9M Buy
+1,276,977
New +$18.9M 40.16% 2

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $667M AUM 45.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aurelius Capital Management's CORZ Position: Q3 2025 in Review

Aurelius Capital Management increased its Core Scientific (CORZ) stake by 7.4% in Q3 2025, buying an estimated $478K and bringing the position to 470,965 shares worth $8.45M. The position accounts for 15.31% of the portfolio, ranked #2.

Aurelius Capital Management first reported a position in CORZ in Q4 2024 and has held it in 4 quarters since. The position peaked at $17.9M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q3 2025.

  • Aurelius Capital Management held 470,965 shares of Core Scientific worth $8.45M as of Q3 2025.
  • Aurelius Capital Management bought 32,571 Core Scientific shares in Q3 2025, an estimated $478K.
  • Core Scientific made up 15.31% of Aurelius Capital Management's portfolio in Q3 2025, its #2 holding.
  • Aurelius Capital Management first reported a position in Core Scientific in Q4 2024 and has held it in 4 quarters since.
  • Aurelius Capital Management's Core Scientific position peaked at $17.9M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q3 2025.

Based on Aurelius Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.